BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1835136)

  • 1. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
    Beller GA; Watson DD
    Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
    Meerdink DJ; Leppo JA
    Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in myocardial perfusion imaging: 99mTc-teboroxime.
    Pieri PL; Strauss HW
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):22-8. PubMed ID: 1450239
    [No Abstract]   [Full Text] [Related]  

  • 4. Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia.
    McGoron AJ; Gerson MC; Biniakiewicz DS; Roszell NJ; Washburn LC; Millard RW
    Eur J Nucl Med; 1997 Dec; 24(12):1479-86. PubMed ID: 9391182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental studies of the physiologic properties of technetium-99m isonitriles.
    Beller GA; Sinusas AJ
    Am J Cardiol; 1990 Oct; 66(13):5E-8E. PubMed ID: 2145747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic properties of myocardial perfusion tracers.
    Dahlberg ST; Leppo JA
    Cardiol Clin; 1994 May; 12(2):169-85. PubMed ID: 8033171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS; Kiat H; Maddahi J
    Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent kinetics of 201Tl and 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion.
    Piwnica-Worms D; Chiu ML; Kronauge JF
    Circulation; 1992 Apr; 85(4):1531-41. PubMed ID: 1313342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi.
    Maublant JC; Moins N; Gachon P; Renoux M; Zhang Z; Veyre A
    J Nucl Med; 1993 Feb; 34(2):255-9. PubMed ID: 8429344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
    Weinstein H; Reinhardt CP; Leppo JA
    J Nucl Med; 1993 Sep; 34(9):1510-7. PubMed ID: 8355072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI).
    Li QS; Solot G; Frank TL; Wagner HN; Becker LC
    J Nucl Med; 1990 Jun; 31(6):1069-76. PubMed ID: 2140856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
    Caner B; Beller GA
    Clin Cardiol; 1998 Apr; 21(4):235-42. PubMed ID: 9562932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations of the myocardial imaging agents 99mTc-MIBI and 201T1 to myocardial blood flow in a canine model of myocardial ischemic insult.
    Canby RC; Silber S; Pohost GM
    Circulation; 1990 Jan; 81(1):289-96. PubMed ID: 2137046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile.
    Sinusas AJ; Trautman KA; Bergin JD; Watson DD; Ruiz M; Smith WH; Beller GA
    Circulation; 1990 Oct; 82(4):1424-37. PubMed ID: 2401074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial kinetics of 99m technetium-Q agents: studies in isolated cardiac myocyte, isolated perfused rat heart, and canine regional myocardial ischemia models.
    McGoron AJ; Biniakiewicz D; Millard RW; Kumar A; Kennedy SC; Roszell NJ; Gabel M; Huth C; Walsh RA; Gerson MC
    Invest Radiol; 1999 Nov; 34(11):704-17. PubMed ID: 10548383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability.
    Sansoy V; Glover DK; Watson DD; Ruiz M; Smith WH; Simanis JP; Beller GA
    Circulation; 1995 Aug; 92(4):994-1004. PubMed ID: 7641384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redistribution of 99mTc-sestamibi and 201Tl in the presence of a severe coronary artery stenosis.
    Sinusas AJ; Bergin JD; Edwards NC; Watson DD; Ruiz M; Makuch RW; Smith WH; Beller GA
    Circulation; 1994 May; 89(5):2332-41. PubMed ID: 8181159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial technetium-99m-teboroxime uptake during adenosine-induced hyperemia in dogs with either a critical or mild coronary stenosis: comparison to thallium-201 and regional blood flow.
    Glover DK; Ruiz M; Bergmann EE; Simanis JP; Smith WH; Watson DD; Beller GA
    J Nucl Med; 1995 Mar; 36(3):476-83. PubMed ID: 7884514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial perfusion imaging with technetium-99m-labeled agents.
    Maddahi J; Kiat H; Berman DS
    Am J Cardiol; 1991 May; 67(14):27D-34D. PubMed ID: 1827941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of flow on technetium-99m-teboroxime (SQ30217) and thallium-201 extraction and retention in rabbit heart.
    Marshall RC; Leidholdt EM; Zhang DY; Barnett CA
    J Nucl Med; 1991 Oct; 32(10):1979-88. PubMed ID: 1919742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.